[Pelvic irradiation and hematopoietic toxicity: A review of the literature].
Fiche publication
Date publication
décembre 2020
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Lien Pubmed
Résumé
Pelvic bone marrow is the site of nearly 50% of total hematopoiesis. Radiation therapy of pelvic lymph node areas, and cancers located near the bony structures of the pelvis, exposes to hematological toxicity in the range of 30 to 70%. This toxicity depends on many factors, including the presence or absence of concomitant chemotherapy and its type, the volume of irradiated bone, the received doses, or the initial hematopoietic reserve. Intensity modulated radiation therapy allows the optimisation of dose deposit on at risk organs while providing optimal coverage of target volumes. However, this suggests that dose constraints should be known precisely to limit the incidence of radiation side effects. This literature review focuses firstly on pelvic lymph node areas and bony volumes nearby, then on the effects of irradiation on bone marrow and the current dosimetric constraints resulting from it, and finally on hematological toxicities by carcinologic location and progress in reducing these toxicities.
Mots clés
Aires ganglionnaires pelviennes, Bone marrow, Hematologic toxicity, IMRT, Moelle osseuse, Pelvic nodes area, RCMI, Radiotherapy, Radiothérapie, Toxicité hématologique
Référence
Cancer Radiother. 2020 Dec 21;: